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PP-128 Polysaccharopeptide stimulated human
peripheral blood mononuclear cells activation
and promoted anti-hepatitis B virus effect
in vitro
L. Xu1 *, L. Lin1, H.L. Wang1, Q. Wang1, G.M. Chen2, Y. Liu3,
C. Wu1. 1Department of Infectious Diseases, Nanjing Drum
Tower Hospital of Nanjing University Medical School,
2Department of Infectious Diseases, Jiangsu Province
Hospital of TCM, 3Department of Laboratory Medicine,
Nanjing Drum Tower Hospital of Nanjing University Medical
School, China
Background: The mechanism of anti-hepatitis B virus effects
of PSP is unclear.
Methods: Human peripheral blood mononuclear Cells
(PBMCs) obtained from healthy volunteer were co-cultured
with PSP. The ratio of CD4+/CD8+ and the expression of
CD3+HLA-DR+ and CD19+CD69+ of PBMCs were assessed
by ﬂow cytometry at 72 hours, meanwhile, detecting the
levels of IFN-g, IL-12 and IgG in supernatant by ELISA. Then
HepG2.2.15 cells were divided into four groups (Table 1).
HBVDNA load and the levels of HBsAg and HBeAg in
supernatant were detected by ﬂuorescent-quantitative PCR
and Abbott-chemiluminescent microparticle immunoassay
respectively at 96 h.
Results: At 72h, the ratio of CD4+/CD8+ in PBMCs+PSP
group was signiﬁcantly higher than PBMCs group (p < 0.05),
and, the expression of CD3+/HLA-DR+ and CD19+/CD69+ in
PBMCs+PSP group were higher than PBMCs group, however,
have no statistical signiﬁcance. PSP could increase IFN-g,
IL-12 and IgG (Graph 1). PSP couldn’t inhibit HBV replication
directly; PBMCs activated by PSP reduced HBsAg and
HBeAg secretion signiﬁcantly, however, have no remarkable
inhibitory effects of HBVDNA (Table 1).
Graph 1. Effect of PSP on IFN-g, IL-12 and IgG secretion by
PBMCs at 72 h (n = 7).
Table 1. Effect of PBMCs activated by PSP on HBsAg, HBeAg and HBV DNA
at 96 h (X±s)
HBsAg HBeAg HBV-DNA
Level
(IU/ml)
Inhibition
rate
Level (S/CO) Inhibition
rate
Inhibition
rate
Treatment group:
(PBMCs co-cultured
with PSP + HepG2.2.15
cells)
4.13±0.92** 50.63%** 24.89±13.67 55.05% 4.78%
Un-treated group:
(PBMCs cultured
without PSP +
HepG2.2.15 cells)
5.86±1.32* 29.40%* 33.29±19.29 39.26% 2.87%
PSP group:
PSP + HepG2.2.15 cells
8.64±1.09 2.88% 50.24±19.99 1.73* 12.28%
Control group:
HepG2.2.15 cells
8.41±0.66 51.67±21.51
Conclusion: The PSP could activate T and B lymphocytes
and increased IFN-g and IL-12 levels of PBMCs, The effect
of HBsAg and HBeAg inhibition owe to the immune response
of PBMCs activated by PSP.
PP-129 Clinical picture of acute viral hepatitis A in
Mongolian children with HBsAg
J. Ulaan1, D. Tungalag2, Y. Dahgwahdorj2 *. 1Center of
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Background: HBV infection is endemic in Mongolia.
So, Mongolian Government launched HBV vaccination as
mandatory immunization since 1991. After that, the
incidence acute viral hepatitis and mortality from acute
liver failure were dramatically decreased. But, it was
not stopped concurrent acute viral hepatitis A and B in
practice.
Purpose of study: To study the clinical picture of acute
viral hepatitis A in children with HBsAg.
Material and Method: In this study, we selected 130 children
(age 1 15; male 84) with acute icteric viral hepatitis, whom
positive detected HBsAg. In 102 children detected only anti-
HA-IgM (1st group), in 8 also anti-HAV-IgM and anti-HBc-IgM
(2nd group) in 20 detected anti-HBc-IgM but not anti-HAV-IgM
(3rd group). Study was conducted at Communicable Diseases
Centre of Mongolia in 2005 2009.
Results: In children for 1st group were severe form 7.8%;
moderate severe form 23.5% cases, then in 2nd group were
severe form 50.0%; moderate severe form were 12.5%; in
3rd group were fulminant form 25.0%, severe form 25.0%
and moderate severe form were 15.0%; There was case
of fulminant liver failure only in acute HBV infection. The
course of clinic manifestations were depending on study
groups shown in the table.
Study groups 1st group
HBsAg(+),
anti-HAV-IgM(+)
anti-HBc-IgM( )
2nd group
HBsAg(+),
anti-HAV-IgM(+)
anti-HBc-IgM(+)
3rd group
HBsAg(+),
anti-HAV-IgM( )
anti-HBc-IgM(+)
Prolongation of intoxication 4 days 6 days 7 days
Prolongation of jaundice 7 days 11 days 12 days
Normalization of GPT 20.2 days 24.6 days 33.4 days
Conclusion: The course of acute Icteric viral hepatitis A in
children with HBsAg predominantly mild as HAV infection.
PP-130 Development and application of Reverse Dot
Blot (RDB) hybridization assay for HBV Pol/RT
resistant mutation
Y.L. Zeng1 *, Y.P. Zhou1, T.S. Zhang2, H.T. He1, W.F. Liang1,
H.H. Huang1, J.F. Wei1, Y.J. Wang1, J.L. Hou1. 1Hepatology
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Hospital, Southern Medical University, Guangzhou 510515,
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Objectives: The purpose of this study was to develop a
method for detecting the mutations at YMDD by reverse dot
blot (RDB) hybridization assay, which was speciﬁc, sensitive
and simple.
Methods: Using LiPA technology principle, we designed
a groups of capture probes with PolyT tail, ﬁxed on
the NC membrane and developed the method Reverse
Dot Blot (RDB) hybridization assay. Sera were collected
from patients with hepatitis B who were predicted to
develop viral breakthrough during lamivudine treatment at
infectious department of NanFang Hospital, between 2006
and 2007. For 134 samples with YMDD mutantion detected by
